MVZ Onkologie im Klinikum Bayreuth GmbH
- Address
- Preuschwitzer Str. 101, 95445 Bayreuth, Germany
Neoplasms Research
At MVZ Onkologie im Klinikum Bayreuth GmbH, the clinical trial portfolio focuses on cancer care, with studies centered on improving treatment outcomes for people with newly diagnosed multiple myeloma and metastatic colorectal cancer. The research is aimed at evaluating how different anti-cancer therapies perform in real patients and whether they can deepen response and extend disease control.
- Multiple myeloma: comparing treatment approaches to improve response quality and support longer-term disease control
- Colorectal cancer: assessing combination treatments to strengthen first-line care for advanced disease
- Cancer therapy: testing how new treatment strategies may improve effectiveness in solid tumors and blood cancers
This research site in Bayreuth contributes to studies that help refine oncology treatment choices and better understand which regimens may offer the most benefit for patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in MVZ Onkologie im Klinikum Bayreuth GmbH
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase II Trial Comparing Trifluridine/Tipiracil with Panitumumab Versus Trifluridine/Tipiracil with Bevacizumab in Metastatic Colorectal Cancer | Charite Universitaetsmedizin Berlin KöR | Phase II | Recruiting | Oct 2021 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bevacizumab | 1 | Unknown | 2021-10-21 | 2021-10-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.